What are Edwards Lifesciences's profit margins?

Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.

Where do Edwards Lifesciences's ratios come from?

Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

Edwards Lifesciences EW Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Gross margin	312.9%-1.6pp	314.6%-1.4pp	316%-1.6pp	317.6%-0.7pp	318.3%-0.1pp
Operating margin	92.3%-4.4pp	96.7%-4.5pp	101.2%-2.3pp	103.5%-1.6pp	105.1%-0.1pp
Net margin	131.3%-58.3pp	189.6%-59.1pp	248.7%-54.9pp	303.6%+44.7pp	258.9%+48.1pp
EBITDA margin	102.7%-4.6pp	107.4%-4.8pp	112.2%-2.5pp	114.6%-1.8pp	116.5%-0.2pp
Returns
Return on equity	81.3%-37.8pp	119%-39.6pp	158.6%-37.5pp	196.1%+24.8pp	171.3%+26.9pp
Return on assets	61.9%-28.4pp	90.4%-29.2pp	119.6%-26.8pp	146.4%+19.7pp	126.6%+21.4pp
Return on invested capital	61%-4.1pp	65.1%-4.7pp	69.8%-4.1pp	73.9%-3.0pp	76.8%-1.3pp
Efficiency
Asset turnover	1.9×0.0×	1.9×0.0×	1.9×0.0×	1.9×-0.1×	2×-0.1×
Inventory turnover	4.7×+0.3×	4.4×+0.1×	4.4×+0.1×	4.2×0.0×	4.2×0.0×
Liquidity
Current ratio	16.8×0.0×	16.9×-0.5×	17.3×+0.5×	16.8×+1.0×	15.8×+0.7×
Quick ratio	13.9×0.0×	13.9×-0.4×	14.3×+0.4×	13.9×+1.0×	12.9×+1.0×
Cash ratio	7.4×-0.5×	7.9×-0.4×	8.3×-0.2×	8.5×+1.0×	7.5×+1.2×
Leverage
Debt-to-equity	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Debt-to-assets	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×	0.2×0.0×
Net debt / EBITDA	-5.6×+0.4×	-6×0.0×	-5.9×+0.6×	-6.6×-1.0×	-5.6×-1.2×
Per Share
Book value per share	$70.79+0.8%	$70.24+1.4%	$69.28+2.2%	$67.81+9.1%	$62.18+9.6%
Valuation
Market capitalization	$185.79B+2.0%	$182.08B+3.3%	$176.27B+3.5%	$170.36B-6.2%	$181.53B-7.7%
Enterprise value	$177.23B+2.6%	$172.81B+3.6%	$166.88B+4.3%	$159.99B-7.4%	$172.78B-8.9%
Price / earnings	132.3×+32.0×	100.3×+35.6×	64.7×+23.8×	40.9×-27.1×	68×-30.5×
Price / sales	31.1×-0.4×	31.4×+0.1×	31.3×+0.3×	31×-2.9×	33.9×-3.5×
Price / book	17.9×+0.3×	17.7×+0.4×	17.3×+0.3×	16.9×-3.3×	20.2×-3.9×
EV / EBITDA	116.2×+4.1×	112.1×+6.3×	105.7×+4.1×	101.7×-8.8×	110.4×-13.3×
EV / sales	29.6×-0.2×	29.8×+0.2×	29.6×+0.5×	29.1×-3.1×	32.3×-3.9×
Earnings yield	16.9%-7.5pp	24.3%-7.4pp	31.7%-7.5pp	39.2%+6.7pp	32.5%+7.4pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Edwards Lifesciences.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are Edwards Lifesciences's profit margins?: Edwards Lifesciences (EW) runs a 77.9% gross margin and a 21.4% operating margin, with a 17.4% net margin.
Where do Edwards Lifesciences's ratios come from?: Every ratio is computed from Edwards Lifesciences's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.